Skip to main content
. Author manuscript; available in PMC: 2014 Aug 27.
Published in final edited form as: Breast Cancer Res Treat. 2005 Jan;89(2):99–105. doi: 10.1007/s10549-004-1474-x

Table 2.

WWOX staining according to histopathological characteristics and ER–PR status

Histopathological characteristics WWOX staining
Total p-Value
Negative Weak Strong
Histology
 Normal tissue 0 (0%) 3 (18.7%) 13 (81.3%) 16
 DCIS 1 (6.6%) 4 (26.7%) 10 (66.7%) 15
 IDCA 69 (34%) 52 (25.6%) 82 (40.4%) 203 p = 0.003a
IDCA ER status
 ER (−) 36 (45.6%) 22 (27.8%) 21 (26.6%) 79
 ER (+) 33 (26.6%) 30 (24.2%) 61 (49.2%) 124 p = 0.003
IDCA ER/PR status*
 ER(−) PR(−) 28 (50.9%) 16 (29.1%) 11 (20%) 55
 ER(+) PR(+) 22 (26.2%) 20 (23.8%) 42 (50%) 84
 ER(+) PR(−) 11 (29.7%) 9 (24.3%) 17 (46%) 37 p = 0.013b
 ER(−) PR(+) 3 (27.3%) 2 (18.2%) 6 (54.5%) 11
*

Not included in this four way analysis 16 cases in which PR status was unavailable.

a

p-Value refers to difference between Normal and IDCA.

b

p-Value refers to difference between ER(−) PR(−) group versus the three other groups.